China Pharma Holdings (CPHI) Cash from Operations (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Cash from Operations came in at 55292.0 in Q1 2026, up 24.95% YoY from 44250.42 in Q1 2025, and down 136.38% on a QoQ basis from 151990.0 in Q4 2025.
China Pharma Holdings (CPHI) Cash from Operations (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Cash from Operations data on file, last reported at 55292.0 in Q1 2026.
- Quarterly Cash from Operations rose 24.95% year-over-year to 55292.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 166645.0 (up 58.08% YoY) and the FY2025 annual result came in at 148261.0, up 136.51% from the prior year.
- Cash from Operations declined to 55292.0 in Q1 2026, from 151990.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1007286.0 in Q3 2023 to a low of 1468214.0 in Q1 2023.
- A 5-year average of 83666.18 and a median of 55292.0 in 2026 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations soared 1438.41% — and 2025, when it tumbled 404.74%.
- Tracing CPHI's Cash from Operations over 5 years: stood at 584594.0 in 2022, then tumbled by 103.82% to 22323.0 in 2023, then soared by 1438.41% to 298773.0 in 2024, then tumbled by 49.13% to 151990.0 in 2025, then sank by 136.38% to 55292.0 in 2026.
- The last three Cash from Operations figures came in at 55292.0 (Q1 2026), 151990.0 (Q4 2025), and 236987.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 | -32,828.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55,292.00 |
| Mar 31, 2026 | -55,292.00 |
| Dec 31, 2025 | 151,990.00 |
| Dec 31, 2025 | 151,990.00 |
| Sep 30, 2025 | -236,987.00 |
| Sep 30, 2025 | -236,987.00 |
| Jun 30, 2025 | 306,934.00 |
| Jun 30, 2025 | 306,934.00 |
| Mar 31, 2025 | -73,676.00 |
| Mar 31, 2025 | -73,676.00 |
| Dec 31, 2024 | 298,773.00 |
| Dec 31, 2024 | 298,773.00 |
| Sep 30, 2024 | -46,952.00 |
| Sep 30, 2024 | -46,952.00 |
| Jun 30, 2024 | -72,726.00 |
| Jun 30, 2024 | -72,726.00 |
| Mar 31, 2024 | -585,158.00 |
| Mar 31, 2024 | -585,158.00 |
| Dec 31, 2023 | -22,323.00 |
| Dec 31, 2023 | -22,323.00 |